Back to Projects
The need for a non-invasive ICP measurement technology
An estimated 25M EU citizens suffer from chronic headaches and over 12M have some form of dementia. Each year, between 3M and 4M suffer head injuries (up to 25% of whom require hospitalization), over 1M suffer strokes and over 100,000 suffer various brain tumours. Intracranial pressure (ICP) monitoring is crucial for surveillance of patients with dementia, chronic headache, hydrocephalus, head injury, stroke, brain tumours and other brain diseases as well as for diagnostic purposes to determine the optimum treatment and for monitoring of effects of treatment. However, all currently available options rely on invasive placement of ICP probe in the patient cerebral spinal fluid, thus reducing its use to the intensive care units or hospital wards. Consequently, less than 100,000 patients receive ICP monitoring in the EU each year.